Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Amazighon Sep 17, 2021 10:31am
83 Views
Post# 33877091

RE:RE:RE:Calm Down

RE:RE:RE:Calm Down
Dude51 wrote: PTBailey please read the article before you defend mgmt.
https://claritasinvestors.com/ Read the article by the invester dude, if Drew assole has not pulled it. It's the kind dicck move he would do. He banned me for speaking my mind on this site. I had no warnings or anything, just dropped me because of what I said about the bs at class on Stock house. That's a dicck move imo. Hey Drew no comeback? I know you read this site, remember that's why you banned me from your site.
 


Hi Dude51,

If you read the whole post (of that specific article), including my comments, you would have known that the person you referring to is not a scientist, but someone who has relatives/acquaintances who suffer from PAH. I explained to that guy that the science he was referring to was of low quality and should not be seen as the standard in the PAH field. It's a science on its own to do a search on the internet and find information that is reliable, sound, and of good quality. It's something scientists have to learn during their training. See for example all those anti-vaxxers who claim that vaccination is bad by referring to mediocre or bad performed research. I myself am a scientist and have CLAS shares, as I know the quality of the science behind R-107 and what is playing on the PAH field. I'm just saying.

As I understand why you were blocked from CI is because you're not invested anymore in CLAS. Being invested in CLAS is a requirement to be a member of CLAS. When you've invested again in CLAS you can be a member again.
However, the way you act on SH recently blaming and having a foulmouth towards Drew, I am afraid that Drew would think twice before allowing you back. Just my opinion.
<< Previous
Bullboard Posts
Next >>